Suggestions
Journal Information
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
Cite
Cite
Share
Download PDF
More article options
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
530
Full text access

CANDIDEMIA IN A HOSPITAL CENTER IN NORTHEAST BRAZIL: AN EVALUATION BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC

Visits
506
Natiane do Nascimento Colares Bitua,
Corresponding author
natianecolares@gmail.com

Corresponding author:
, Anne Helen Barreto Meloa, Manoel Roberto Franco Ramos Netoa, Alicya Beatriz França dos Santosa, Jesiel Magalhães de Andradea, Zayra Hellen de Abreu Alexandrea,b, Jacó Ricarte Lima de Mesquitab, Rossana de Aguiar Cordeirob, Lisandra Serra Damascenoa,b
a Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
b Hospital São José de Doenças Infecciosas, Fortaleza, CE, Brazil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 30. Issue S1

XXIV Brazilian Congress of Infectious Diseases 2025

More info
Introduction/Objectives

Candidemia is a systemic infection caused by yeasts of the genus Candida. It is widely recognized as a major cause of morbidity and mortality in healthcare settings. The aim of this study was to evaluate the occurrence of candidemia from 2018–2024 in a public hospital in Ceará, Brazil.

Methods

A retrospective cohort study was conducted in patients diagnosed with candidemia. Demographic, clinical, laboratory, and microbiological data were collected from medical records. Three periods were considered: pre-pandemic (2018–2019), pandemic (2020–2022), and post-pandemic (2023–2024). Statistical analysis was performed using STATA 18.0.

Results

Sixty cases of candidemia were identified. Most occurred in the pandemic period (n = 39). Males were more affected in all periods (p = 0.761). The proportion of patients aged > 60 years was similar between periods (p = 1.000). In the pre-pandemic period (n = 6), 50% were people living with HIV/AIDS (PLWHA), while 36% and 33% were PLWHA in subsequent periods (p = 0.840). COVID-19-associated candidemia occurred predominantly during the pandemic compared to the post-pandemic period (41% vs. 13.3%; p = 0.030). The use of invasive devices and broad-spectrum antimicrobials was similar across periods (p > 0.05). Detection of candidemia after >10 days of hospitalization was less frequent in the pandemic and post-pandemic periods compared to the pre-pandemic period, but without statistical significance (p = 0.253). Identification of Candida albicans was similar across periods (33.3% vs. 35.9% vs. 26.7%; p = 0.913). Isolation of C. tropicalis and C. krusei occurred beginning in the pandemic period. One case of C. pelliculosaassociated with COVID-19 was identified post-pandemic. Most pre-pandemic patients had hospital stays > 30 days (p = 0.030). Mortality was high in all three periods (83.3% vs. 69.2% vs. 80%; p = 0.668).

Conclusion

The COVID-19 pandemic directly impacted the increased number of candidemia cases and the emergence of non-albicans Candida species in this institution. Continuous surveillance of critically ill patients is necessary for early identification and better clinical management.

Keywords:
Candidemia
COVID-19, Candida
PDF
Full text is only available in PDF
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools